CORRECTION article

Front. Oncol., 23 February 2022

Sec. Radiation Oncology

Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.853278

Corrigendum: A Novel Role of Connexin 40-Formed Channels in the Enhanced Efficacy of Photodynamic Therapy

  • 1. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Pharmacy School of Xuzhou Medical University, Xuzhou, China

  • 2. Department of Pharmacology, Pharmacy School of Xuzhou Medical University, Xuzhou, China

  • 3. Department of Pharmacy, Wuxi Ninth Affiliated Hospital of Suzhou University, Wuxi, China

  • 4. Scientific Research Center of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, China

Article metrics

View details

1

Citations

832

Views

458

Downloads

In the original article, there was a mistake in Figure 5 as published. After confirmation, we found that the representative images of the flow cytometer of Dox-untreated and Dox-treated control group (panel A) and Photofrin group (panel E) in Figure 5 were misused due to our carelessness in the selection of representative images for image combination using software of flow cytometer. The corrected Figure 5 appears below.

Figure 5

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Connexin 40, channel, photodynamic therapy, reactive oxygen species, calcium

Citation

Wu D-P, Bai L-R, Lv Y-F, Zhou Y, Ding C-H, Yang S-M, Zhang F, Wang Y-Y, Huang J-L and Yin X-X (2022) Corrigendum: A Novel Role of Connexin 40-Formed Channels in the Enhanced Efficacy of Photodynamic Therapy. Front. Oncol. 12:853278. doi: 10.3389/fonc.2022.853278

Received

12 January 2022

Accepted

19 January 2022

Published

23 February 2022

Volume

12 - 2022

Edited and reviewed by

Valdir Carlos Colussi, University Hospitals Cleveland Medical Center, United States

Updates

Copyright

*Correspondence: Xiao-Xing Yin,

†These authors have contributed equally to this work

This article was submitted to Radiation Oncology, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics